Vectus Biosystems (ASX:VBS) EV-to-EBITDA : -0.54 (As of Jul. 12, 2025)

Vectus Biosystems EV-to-EBITDA Chart

Vectus Biosystems Annual Data
	Trend	Jun16	Jun17	Jun18	Jun19	Jun20	Jun21	Jun22	Jun23	Jun24
EV-to-EBITDA		Get a 7-Day Free Trial				-8.14	-12.04	-12.33	-6.42	-1.46

Vectus Biosystems Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EV-to-EBITDA	Get a 7-Day Free Trial													-	-6.42	-	-1.46	-

Competitive Comparison of Vectus Biosystems's EV-to-EBITDA

For the Biotechnology subindustry, Vectus Biosystems's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vectus Biosystems's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vectus Biosystems's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Vectus Biosystems's EV-to-EBITDA falls into.

Vectus Biosystems EV-to-EBITDA Calculation

Vectus Biosystems's EV-to-EBITDA for today is calculated as:

Vectus Biosystems's current Enterprise Value is A$1.19 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Vectus Biosystems's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was A$-2.21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vectus Biosystems  (ASX:VBS) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Vectus Biosystems's PE Ratio (TTM) for today is calculated as:

Vectus Biosystems's share price for today is A$0.037.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Vectus Biosystems's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.043.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Vectus Biosystems EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Vectus Biosystems Business Description